-
Several Rho Experts to Present at Annual PharmaSUG Conference
May 29, 2014, 00:00 AM by Michael CroftCHAPEL HILL, NC, UNITED STATES - May 29, 2014 - Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced its participation at the 2014 Annual Pharmaceutical Industry SAS Users Group (PharmaSUG) Conference June 1-4 in San DiegoFull story -
RCRI Appoints Christine Lys as West Coast Senior Business Development Advisor
May 29, 2014, 00:00 AM by Michael CroftMINNEAPOLIS, MN - May 29, 2014 - RCRI Appoints Christine Lys as West Coast Senior Business Development AdvisorBefore joining RCRI, Christine Lys, MFull story -
Annual Dotmatics Days in Boston and San Francisco
May 29, 2014, 00:00 AM by Michael CroftBISHOP'S STORTFORD, UK - May 29, 2014 - ~~Dotmatics, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, will host the scientific community at Dotmatics Days in the biotech hubs of Boston and San FranciscoFull story -
MolecularHealth Signs Internationally-Recognized Oncology Expert to Advisory Board
May 29, 2014, 00:00 AM by Michael CroftTHE WOODLANDS, TX, UNITED STATES - May 29, 2014 - Today, MolecularHealth announced Waun Ki Hong, M.D., as the newest member of its advisory board. Dr. Hong is one of the nations leading experts on head, neck and lung cancers, recently honored by ASCOs Oncology Luminaries seriesFull story -
Twist Bioscience Takes in Funding Round for DNA Synthesizer
May 28, 2014, 10:25 AM by Michael CroftXconomy | Twist Bioscience yesterday announced a $26 million Series B funding round, as well as a $5 million DARPA contract, to continue development of a high-throughput DNA synthesis device.Full story -
ARRAY BIOPHARMA ANNOUNCES DRUG DISCOVERY COLLABORATION AGREEMENT WITH BIOGEN IDEC
May 28, 2014, 00:00 AM by Michael CroftBOULDER, CO, UNITED STATES - May 28, 2014 - Array BioPharma (Nasdaq: ARRY) announced today a collaboration agreement with Biogen Idec (NASDAQ: BIIB) for the discovery and development of inhibitors targeting a novel kinase for the treatment of autoimmune disordersFull story -
TELCOR Named Microsoft® Partner for 15th Straight Year
May 28, 2014, 00:00 AM by Michael CroftLINCOLN, NE - May 28, 2014 - TELCOR Inc announced today it has achieved the prestigious Microsoft Partner status through Microsoft CorpFull story -
Rho to Use Clinical Trial Oversight Summit as Platform to Share Best Practices in Clinical Monitoring
May 28, 2014, 00:00 AM by Michael CroftCHAPEL HILL, NC, UNITED STATES - May 28, 2014 - Rho to Use Clinical Trial Oversight Summitas Platform to Share Best Practices in Clinical MonitoringClinical trial thought leaders share insight on risk-based monitoring, monitoring with EDC, and the importance of strong relationships between sites and CROs WHAT: Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced its participation at the 5th Annual Clinical Oversight Summit in Boston as a sponsorFull story -
Thomson Reuters Report Identifies BRIC Nations as Emerging Leaders in Global Clinical Trials Landscape
May 28, 2014, 00:00 AM by Michael CroftPHILADELPHIA, PA - May 28, 2014 - The Intellectual Property & Science business of Thomson Reuters, the world leader in providing intelligent information to businesses and professionals, today announced the release of Overcoming Clinical Challenges in BRIC Markets, a report exploring the benefits and challenges of conducting clinical trials in the pharmaceutical markets of the BRIC nations: Brazil, Russia, India and ChinaFull story -
Design your target-focused library with OTAVA
May 28, 2014, 00:00 AM by Michael CroftTORONTO, КАНАДА - May 28, 2014 - The key goal during drug design process is to limit the number of compounds among large number of available ligands for experimental testingFull story -
Build up your compounds using chemical building blocks from OTAVA!
May 26, 2014, 00:00 AM by Michael CroftTORONTO, CANADA - May 26, 2014 - OTAVA specializes in synthesis and distribution of quality chemical building blocks. You could request custom synthesis of chemical compounds of your interest, for this purpose just send single or multiple structures as attached files by filling the form at the OTAVAs web-site (http://wwwFull story -
Quantapore Receives $35m Investment Toward New Sequencer
May 22, 2014, 16:00 PM by Michael CroftSan Francisco Business Times | An ex-Ion Torrent scientist has a $35 million investment to prove his new sequencer is faster and cheaper than anything else.Full story -
Advances in Genetic Engineering at the 2014 American Society for Microbiology Meeting
May 22, 2014, 07:55 AM by Michael CroftBio-IT World | Presenters at the annual meeting of the American Society for Microbiology showed off new applications for the CRISPR system of gene editing, and projects that have re-coded bacterial genomes on a massive scale.Full story -
GenePeeks Launches Sperm Donor Matching Service
May 22, 2014, 07:00 AM by Michael CroftBio-IT World News Brief | GenePeeks has opened its in silico nursery, formally launching the Matchright screening service for families who are planning to use a sperm donor to conceive.Full story -
N-of-One Signs Agreement with Mayo Clinic
May 21, 2014, 13:00 PM by Michael CroftBio-IT World News Brief | Mayo Clinic and N-of-One, have signed an agreement under which N-of-One will provide Mayo Clinic with clinical interpretation information to aid in highly complex molecular diagnostics.Full story -
QIAGEN Adds HGMD and Other BIOBASE Offerings, Plans Ingenuity Clinical
May 21, 2014, 12:00 PM by Michael CroftBio-IT World News Brief | QIAGEN is adding content from BIOBASE including HGMD, the human gene mutation database, to its bioinformatics offerings. HGMD and other BIOBASE solutions will provide the foundation for Ingenuity Clinical, QIAGEN's forthcoming clinical NGS decision-support solution.Full story -
A European Look at the Changing Landscape of Prenatal Testing
May 21, 2014, 07:00 AM by Michael CroftBio-IT World | At the Prenatal Molecular Diagnostics Europe conference last week in Lisbon conversations ranged from the current landscape in prenatal diagnostics to the future vision of the technology and the regulatory environment that will enable it.Full story -
Medidata and TransCelerate BioPharma Inc. Announce Joint Initiative
May 20, 2014, 12:00 PM by Michael CroftFull storyNEW YORK, N.Y. – May 20, 2014 – Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it is partnering with TransCelerate BioPharma Inc. ("TransCelerate") on a project designed to inform the nonprofit organization’s continued efforts to modernize and streamline the way clinical trials are conducted and monitored worldwide.
-
Rho Expands Team in Research Triangle Park, Continues Hiring
May 20, 2014, 00:00 AM by Michael CroftCHAPEL HILL, NC, UNITED STATES - May 20, 2014 - Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced it has added 14 professionals to its Research Triangle Park team in April and has plans to hire an additional 25 more team members as part of its growth expansion strategy in 2014Full story -
At AstraZeneca, Occasion for Introspection
May 19, 2014, 12:30 PM by Michael CroftBio-IT World | On Friday, a frank assessment of AstraZeneca's R&D practices appeared in Nature Reviews Drug Discovery, just as Pfizer's repeated takeover bids have increased scrutiny of AstraZeneca's drug development pipeline.Full story